$231.35
-17.34-6.97%
Last update: Nov 12, 5:50 PM
Moderna Inc (MRNA) Stock Price, Quote, News & History
MRNANASDAQ
Moderna raises its 2026 revenue forecast to 15%-25% and accelerates oncology investments, expanding its mRNA platform into new therapies.
You can purchase shares of Moderna (NASDAQ:MRNA) through any online brokerage.
Other companies in Moderna’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Moderna has a consensus price target of $85.83.
The stock price for Moderna (NASDAQ: MRNA) is $231.46 last updated November 12, 2026 at 5:50 PM EST.
There are no upcoming dividends for Moderna.
Moderna does not have any upcoming earnings scheduled.
There is no upcoming split for Moderna.
Moderna is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna...
